Seroquel Tablet, Extended Release
Product Images NDC 61269-271

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Seroquel (NDC 61269-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Figure 1)

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Figure 1)
A line graph showing the proportion of patients with relapse (%) over time in months. Two lines represent different groups: PLA (placebo) with a dashed line and QTP XR (quetiapine extended-release) with a solid line. The graph shows a higher relapse proportion in the placebo group compared to the QTP XR group over up to 7 months.*
FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Figure 2)

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Figure 2)
A line graph depicting the proportion of patients with relapse over time in weeks. Two curves are shown: one for QTP+ LI/VAL (quetiapine plus lithium or valproate) with a lower relapse proportion and another for PLA+ LI/VAL (placebo plus lithium or valproate) with a higher relapse proportion. The graph illustrates relapse trends up to 100 weeks.*
FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Figure 3)

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Figure 3)
A line graph showing the proportion of patients with relapse (%) over time in weeks. Two groups are compared: QTP+LI/VAL indicated by a dashed line, and PLA+LI/VAL indicated by a solid line. The graph tracks relapse rates across approximately 100 weeks, with the PLA+LI/VAL group showing a higher proportion of relapse over time than the QTP+LI/VAL group.*
FDA Label Image

Seroquel Xr 50 mg 60 Tablets Bottle Label (Ndc61269 270 60)

Seroquel Xr 50 mg 60 Tablets Bottle Label (Ndc61269 270 60)
The image shows a label for SEROQUEL XR (quetiapine) extended-release tablets in a 50 mg strength. The label indicates a quantity of 60 tablets. It includes the NDC number 61269-270-60 and notes the product is Rx only with medication guide dispensing instructions. The labeler is Cheplapharm.*
FDA Label Image

Seroquel Xr 150 mg 60 Tablets Bottle Label (Ndc61269 271 60)

Seroquel Xr 150 mg 60 Tablets Bottle Label (Ndc61269 271 60)
Label for SEROQUEL XR (quetiapine) extended-release tablets, 150 mg strength. The label indicates 60 tablets per container and includes the NDC number 61269-271-60. It specifies prescription use only and includes a medication guide warning. The label shows the manufacturer as CHEPLAPHARM.*
FDA Label Image

Seroquel Xr 200 mg 60 Tablets Bottle Label (Ndc61269 272 60)

Seroquel Xr 200 mg 60 Tablets Bottle Label (Ndc61269 272 60)
SEROQUEL XR 200 mg extended-release tablets packaging label showing a bottle containing 60 tablets. The label includes the generic name quetiapine, the dosage strength of 200 mg, and a note that medication guide must be dispensed. The labeler is CHEPLAPHARM.*
FDA Label Image

Seroquel Xr 300 mg 60 Tablets Bottle Label (Ndc61269 273 60)

Seroquel Xr 300 mg 60 Tablets Bottle Label (Ndc61269 273 60)
Label for SEROQUEL XR (quetiapine) extended-release tablets, 300 mg strength. The label indicates a package containing 60 tablets, for oral use. It includes prescribing restrictions (Rx only) and a note that a Medication Guide must be dispensed. The labeler is CHEPLAPHARM.*
FDA Label Image

Seroquel Xr 400 mg 60 Tablets Bottle Label (Ndc61269 274 60)

Seroquel Xr 400 mg 60 Tablets Bottle Label (Ndc61269 274 60)
Label for SEROQUEL XR 400 mg extended-release tablets, oral dosage form by H2-Pharma, LLC. The label shows a package containing 60 tablets and includes the NDC 61269-274-60. It states the generic name quetiapine and instructs that medication guide must be dispensed to patients. The dosage strength and manufacturer branding CHEPLAPHARM are also visible.*
FDA Label Image

Structural Formula (Chemical Structure)

Structural Formula (Chemical Structure)
Chemical structure diagram illustrating the quetiapine molecule, the active ingredient in SEROQUEL XR extended-release tablets. The figure shows the molecular arrangement of quetiapine and its associated chemical groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.